Our mediation analyses indicated significant indirect effects of maternal folate on GDM risk via each placental hormone individually: GH2 increased risk, whereas hPL reduced risk, findings that are consistent with their established physiological roles in promoting maternal insulin resistance and insulin secretion, respectively [17,18,35]. This evidence concerns the gene GH2 and gestational diabetes.